Maryam Borhani-Haghighi

Dr. Maryam Borhani-Haghighi


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Cellular Reprogramming
Verified
Journal Article
Closed access
PNParastoo Noory
Parastoo Noory
SNShadan Navid
Shadan Navid
BZBagher Minaee Zanganeh
Bagher Minaee Zanganeh
ATAli Talebi
Ali Talebi
MBMaryam Borhani-Haghighi
Maryam Borhani-Haghighi
MAMehdi Abbasi
Mehdi Abbasi
We recently reported the application of human menstrual blood stem cells' (HuMenSCs) transplantation as a treatment modality in a rat model of premature ovarian failure (POF). We continued to investigate further in this respect. Female rats were injected intraperitoneally with 36 mg/kg busulfan. HuMenSCs were obtained, grown, and analyzed for immunophenotypic features at passage three. The cells were labeled with CM-Dil and infused into the rats. There were four groups: normal, negative control, treatment, and Sham. One month after treatment, the ovaries were collected and weighed. Histological sections were prepared from the ovary and HuMenSCs were tracking. Subsequently, we examined the changes of expression of Bax and B cell lymphoma 2 (Bcl2) genes by real-time polymerase chain reaction assay. One month after HuMenSCs transplantation, these cells were located in the ovarian interstitium and granulosa cells (GCs). The number of TUNEL-positive cells significantly decreased in the treatment group. Also the expression level of Bax genes, unlike Bcl2 gene, significantly decreased compared with negative and sham groups. In our study, HuMenSCs were tracked in ovarian tissues within 2 months after transplantation, and they differentiated into GCs. Therefore, the use of these cells can be a practical and low-cost method for the treatment of POF patients.

30 April 2020 in Asian Spine Journal
Verified
Journal Article
Open access
PDF file
MBMaryam Borhani-Haghighi
Maryam Borhani-Haghighi
SNShadan Navid
Shadan Navid
YMYousef Mohamadi
Yousef Mohamadi
Study Design: Experimental animal study.Purpose: This study investigated the therapeutic effects of human breast milk stem cell (BMSC)-conditioned medium (BMSC-CM) in a model of spinal cord injury (SCI) in male Sprague-Dawley rats.Overview of Literature: SCI is one of the leading causes of disability in addition to sensory and motor impairment. So far, there have been no successful treatments for SCI. Given the positive outcomes associated with using stem cells and their derivatives as a treatment for various diseases, there is a growing interest in using them as an SCI treatment. Recent research has demonstrated that CM from stem cells has therapeutic advantages.Methods: Human BMSCs were isolated and characterized, and CM was subsequently collected. Animals received an intrathecal administration of BMSC-CM after SCI. The activity of caspase-3 was measured to assess apoptosis, and levels of tumor necrosis factor-α and interleukin-1β were measured to assess inflammation. Also, sensory and locomotor performances were assessed after SCI and BMSC-CM administration.Results: Administration of CM from BMSC reduced apoptosis and inflammation at the site of injury in a rat model of SCI (p<0.05). Motor, sensory, locomotor, and sensorimotor performances were significantly improved in rats that received BMSC-CM after SCI.Conclusions: Intrathecal administration of BMSC-CM improved recovery in a rat model of SCI.

1 May 2019 in Brain Research
Verified
Journal Article
Closed access
AJAli Jahanbazi Jahan-Abad
Ali Jahanbazi Jahan-Abad
SKSaeed Karima
Saeed Karima
SNSajad Sahab Negah
Sajad Sahab Negah
FNFarshid Noorbakhsh
Farshid Noorbakhsh
MBMaryam Borhani-Haghighi
Maryam Borhani-Haghighi
Ali GorjiAli Gorji
Ali Gorji

12 March 2019 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
MBMaryam Borhani-Haghighi
Maryam Borhani-Haghighi
YMYousef Mohamadi
Yousef Mohamadi
IKIraj Ragerdi Kashani
Iraj Ragerdi Kashani

1 September 2016 in The Neuroscience Journal of Shefaye Khatam
Verified
Journal Article
Open access
PDF file
HMHoda Pasand Mojdeh
Hoda Pasand Mojdeh
FAFatemeh Alipour
Fatemeh Alipour
MBMaryam Borhani-Haghighi
Maryam Borhani-Haghighi
Introduction: Alzheimer's disease (AD) is described by structural and functional disturbances of the human brain. The amyloid fibril proteins are located and deposited inside neurons as neurofibrillary tangles. These are also deposited extracellular compartment as amyloid plaques. These changes are accompanied by the progressive disorder and loss of nerve cells ...